Cadre (NYSE:CDRE) PT Lowered to $25.00 at Stifel Nicolaus

Cadre (NYSE:CDRE – Get Rating) had its price target lowered by Stifel Nicolaus from $28.00 to $25.00 in a research report released on Thursday, Benzinga reports. The firm currently has a hold rating on the stock.

A number of other research analysts also recently weighed in on CDRE. Lake Street Capital lowered their price objective on shares of Cadre from $30.00 to $28.00 in a research report on Thursday. Stephens upped their target price on shares of Cadre to $32.00 in a report on Wednesday, November 16th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of Moderate Buy and a consensus price target of $31.00.

Cadre Stock Up 0.4 %

Shares of Cadre stock opened at $19.02 on Thursday. The company has a market cap of $710.02 million, a price-to-earnings ratio of 158.50 and a beta of 1.66. The company’s 50 day moving average is $22.16 and its 200 day moving average is $24.26. Cadre has a twelve month low of $16.58 and a twelve month high of $31.50. The company has a quick ratio of 1.46, a current ratio of 2.53 and a debt-to-equity ratio of 0.89.

Cadre Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 17th. Stockholders of record on Friday, February 3rd were paid a $0.08 dividend. The ex-dividend date of this dividend was Thursday, February 2nd. This represents a $0.32 dividend on an annualized basis and a dividend yield of 1.68%. Cadre’s dividend payout ratio (DPR) is presently 266.67%.

Insider Transactions at Cadre

In other news, Director Nicolas Sokolow sold 5,000 shares of the stock in a transaction on Thursday, December 22nd. The shares were sold at an average price of $20.29, for a total value of $101,450.00. Following the completion of the sale, the director now directly owns 120,179 shares of the company’s stock, valued at $2,438,431.91. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, CEO Warren B. Kanders sold 26,423 shares of the stock in a transaction on Friday, December 23rd. The shares were sold at an average price of $20.08, for a total value of $530,573.84. Following the completion of the sale, the chief executive officer now directly owns 15,761,655 shares of the company’s stock, valued at $316,494,032.40. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Nicolas Sokolow sold 5,000 shares of the stock in a transaction on Thursday, December 22nd. The stock was sold at an average price of $20.29, for a total transaction of $101,450.00. Following the completion of the sale, the director now directly owns 120,179 shares of the company’s stock, valued at $2,438,431.91. The disclosure for this sale can be found here. Insiders sold a total of 31,739 shares of company stock valued at $638,849 over the last three months. Corporate insiders own 52.93% of the company’s stock.

Institutional Trading of Cadre

A number of hedge funds and other institutional investors have recently modified their holdings of CDRE. Point72 Middle East FZE purchased a new position in Cadre during the fourth quarter valued at $37,000. Tower Research Capital LLC TRC grew its stake in Cadre by 75.8% during the third quarter. Tower Research Capital LLC TRC now owns 2,322 shares of the company’s stock valued at $56,000 after acquiring an additional 1,001 shares in the last quarter. Federated Hermes Inc. purchased a new position in Cadre during the first quarter valued at $60,000. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in Cadre during the fourth quarter valued at $51,000. Finally, Amalgamated Bank grew its stake in Cadre by 18.1% during the third quarter. Amalgamated Bank now owns 3,084 shares of the company’s stock valued at $74,000 after acquiring an additional 473 shares in the last quarter. 34.09% of the stock is owned by hedge funds and other institutional investors.

About Cadre

(Get Rating)

Cadre Holdings, Inc manufactures and distributes safety and survivability equipment that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It primarily provides body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brands; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective and law enforcement equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.